By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: Del Bigtree and ICAN Announce Senate Hearing on Science and Corruption, Featuring Groundbreaking Study and Announce Documentary, “An Inconvenient Study”
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > Health > Del Bigtree and ICAN Announce Senate Hearing on Science and Corruption, Featuring Groundbreaking Study and Announce Documentary, “An Inconvenient Study”
Del Bigtree and ICAN Announce Senate Hearing on Science and Corruption, Featuring Groundbreaking Study and Announce Documentary, “An Inconvenient Study”
Health

Del Bigtree and ICAN Announce Senate Hearing on Science and Corruption, Featuring Groundbreaking Study and Announce Documentary, “An Inconvenient Study”

GlobeNews Wire
Last updated: 09/09/2025 11:36 PM
GlobeNews Wire
Published: 09/09/2025
Share
SHARE

WASHINGTON, DC, Sept. 09, 2025 (GLOBE NEWSWIRE) — The Informed Consent Action Network (ICAN), led by Emmy Award-winning producer and veteran medical journalist Del Bigtree, today calls attention to a crucial hearing of the U.S. Senate Permanent Subcommittee on Investigations titled “How the Corruption of Science Has Impacted Public Perception and Policies Regarding Vaccines.” The hearing, set for September 9, 2025 at 2:00 PM in Room SH-216 of the Senate Hart Building, will spotlight an alarming study conducted by a top infectious disease expert at a premier healthcare institution, which looks at the health outcomes of vaccinated kids vs. those of fully unvaccinated kids. The study was hidden from the public for years, until this hearing by the Homeland Security Committee.

The hearing’s revelations are dramatically mirrored in An Inconvenient Study, an investigative documentary set for nationwide release on October 3, 2025. This documentary will disclose the origins of the study featured in the hearing. How in 2016, Del Bigtree convinced the head of infectious disease at one of the most prestigious healthcare institutions in the world to conduct the most thorough vaccinated vs. unvaccinated study that has ever been done–and how this institution succeeded in burying the results.

ICAN’s lead counsel, Aaron Siri, Esq., will present the study’s shocking findings as he does in his new book, Vaccines, Amen, laying bare the legal and scientific implications of systemic corruption. As the film’s legal lead, Mr. Siri will illustrate why the evidence demands immediate public scrutiny.

Del Bigtree, Emmy-winning former producer of The Doctors, stated:

“What is so incredible is that a pro-vaccine scientist at a pro-vaccine medical institution conducted a study to prove “anti-vaxxers” wrong, but instead produced one of the most damning indictments of the vaccine program ever seen. We are facing a crisis in public health transparency, and the American people deserve the truth now.”

National press, policy advocates, public health stakeholders, and concerned citizens: view the hearing at thehighwire.com/watch, and updates and early access to trailers and more for An Inconvenient Study, launching October 3. Sign up at aninconvenientstudy.com

Release Highlights

Element Details
Hearing Title How the Corruption of Science Has Impacted Public Perception and Policies Regarding Vaccines
Date & Time September 9, 2025, 2:00 PM (Senate Hart Building, SH-216) Homeland Security Committee
Film Title An Inconvenient Study: The Cause of America’s Chronic Disease Epidemic Exposed, documentary feature
Film Release Date October 3, 2025
Key Figures Del Bigtree (Producer, ICAN CEO), Aaron Siri, Esq. (Lead Attorney, ICAN)


Hindustan Coca-Cola Beverages Names New CEO
HR Path Continues to Expand its Presence in the U.S. Market with the Acquisition of Next Generation Inc. (NGI)
Indian Investment into UK At an All Time High
Apivia Courtage Brings Agentic AI to its Contact Centers With SoundHounds Amelia 7 Platform
Celcuity to Announce Topline Results for the PIK3CA Wild-Type Cohort from Phase 3 VIKTORIA-1 Trial in HR+/HER2- Advanced Breast Cancer
TAGGED:“anandannouncebigtreecorruptiondeldocumentaryfeaturinggroundbreakinghearingicaninconvenientnewsSciencesenate,study
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
Constant Evolution for the Intelligent AIoT Future: Dahua Technology Unveils Xinghan Large-scale AI Models
News

Constant Evolution for the Intelligent AIoT Future: Dahua Technology Unveils Xinghan Large-scale AI Models

20/09/2025
CCTV+: China Up Close: Zhejiang Tour Explores Deqing
Comarch and F.I.L.A. S.p.A. strengthen the collaboration with the extension of electronic invoicing at the European level
NYSE Content Advisory: Pre-Market Update + President of South Korea rings Opening Bell
GLG Publishes Report on Impact of U.S. Tariffs on Asia-Pacific Businesses
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?